This is the authors' abstract. We don't add key points for this paper.
Gestational Diabetes Mellitus (GDM) is defined as glucose intolerance with first recognition during pregnancy. With the new IADPSG diagnostic criteria the prevalence of GDM increases significantly worldwide. The potential risks of GDM for mother and child both in the short and long term urge more treatments to be explored. Resistant starches as a prebiotics has been shown possessing multiple health benefits including improving glucose tolerance and insulin sensitivity. Altered gut fermentation and microbiota and sequential enhancement in blood gut peptides (i.e. GLP-1) are suggested mechanisms involved. The goal of this paper is to provide a brief overview on GDM and the role of RS in the treatment of GDM.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: